The document discusses various in vivo and in vitro models used to screen anti-arrhythmic drugs. It describes methods like chemically induced arrhythmia using aconitine in rats, electrically induced arrhythmias using current stimulation in dogs, exercise induced ventricular fibrillation in dogs, and mechanically induced arrhythmias through coronary artery ligation and reperfusion in dogs. The screening aims to evaluate drugs for their ability to prevent arrhythmias like ventricular tachycardia, fibrillation, and changes in hemodynamic parameters and mortality.